State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report.
Josee-Lyne EthierKatherine C FuhRebecca ArendGottfried E KonecnyPanagiotis A KonstantinopoulosKunle OdunsiElizabeth M SwisherElise C KohnDmitriy ZamarinPublished in: JCO precision oncology (2022)
Although a number of biomarkers of response to various agents in OC have been described in the literature, high-level evidence for the majority is lacking. This report highlights the unmet need for identification and validation of predictive biomarkers to guide therapy and future trial design in OC.